BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6150706)

  • 1. Glutamic acid and glutamine levels in serum and cerebrospinal fluid in hepatic encephalopathy.
    Watanabe A; Takei N; Higashi T; Shiota T; Nakatsukasa H; Fujiwara M; Sakata T; Nagashima H
    Biochem Med; 1984 Oct; 32(2):225-31. PubMed ID: 6150706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CSF in hepatic encephalopathy.
    Plum F
    Exp Biol Med; 1971; 4():34-41. PubMed ID: 5162459
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.
    Cascino A; Cangiano C; Fiaccadori F; Ghinelli F; Merli M; Pelosi G; Riggio O; Rossi Fanelli F; Sacchini D; Stortoni M; Capocaccia L
    Dig Dis Sci; 1982 Sep; 27(9):828-32. PubMed ID: 7105954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ammonia on plasma and cerebrospinal fluid amino acids in dogs with and without portacaval anastomoses.
    Schäfer K; Ukida M; Steffen C; Bode C; Zelder O; Bode JC
    Res Exp Med (Berl); 1985; 185(1):35-44. PubMed ID: 2857496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired metabolism of methionine in severe liver diseases. II. Clinical and experimental studies on role of impaired methionine metabolism in pathogenesis of hepatic encephalopathy.
    Higashi T
    Gastroenterol Jpn; 1982 Apr; 17(2):125-34. PubMed ID: 7106499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy.
    Mizock BA; Sabelli HC; Dubin A; Javaid JI; Poulos A; Rackow EC
    Arch Intern Med; 1990 Feb; 150(2):443-9. PubMed ID: 2302019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.
    Rössle M; Luft M; Herz R; Klein B; Lehmann M; Gerok W
    Klin Wochenschr; 1984 Sep; 62(18):867-75. PubMed ID: 6149332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
    Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
    Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation.
    Schmidt W; Wolf G; Grüngreiff K; Meier M; Reum T
    Metab Brain Dis; 1990 Mar; 5(1):19-31. PubMed ID: 1970850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine values in cerebrospinal fluid of children: some observations on clinical application.
    Zacarías J; Harum A; Brinck P
    J Pediatr; 1971 Feb; 78(2):318-21. PubMed ID: 5539779
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral metabolism during cross-circulation in experimental hepatic failure in the pig.
    Tønnesen K
    Liver; 1986 Oct; 6(5):268-74. PubMed ID: 2878338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of ascorbic acid on ammoniemia, alpha-ketoglutaric acid, glutamic acid and glutamine in cirrhotic and normal subjects].
    Schirardin H; Bauer M; Warter J
    C R Seances Soc Biol Fil; 1967; 161(10):2060-4. PubMed ID: 4234199
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-ketoglutaramate, a neurotoxic agent in hepatic coma.
    Vergara F; Duffy TE; Plum F
    Trans Assoc Am Physicians; 1973; 86():255-63. PubMed ID: 4788800
    [No Abstract]   [Full Text] [Related]  

  • 15. Ammonia: key factor in the pathogenesis of hepatic encephalopathy.
    Butterworth RF; Giguère JF; Michaud J; Lavoie J; Layrargues GP
    Neurochem Pathol; 1987; 6(1-2):1-12. PubMed ID: 3306479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy.
    Butterworth RF; Lavoie J; Giguère JF; Layrargues GP; Bergeron M
    Neurochem Pathol; 1987; 6(1-2):131-44. PubMed ID: 2888065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ammonia, glutamine and glutamic acid content of rat tissues during and after hyperoxia].
    Gabibov MM
    Kosm Biol Aviakosm Med; 1975; 9(2):12-6. PubMed ID: 1123898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress.
    Lemberg A; Fernández MA
    Ann Hepatol; 2009; 8(2):95-102. PubMed ID: 19502650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electroencephalography and cerebrospinal fluid glutamine in portal-systemic encephalopathies].
    Gonçalves e Silva GE; Travassos FM; Barreto FJ
    Arq Neuropsiquiatr; 1982 Dec; 40(4):339-55. PubMed ID: 7171336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.